Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Xiang-Yang Han Image

      Xiang-Yang Han, MD, PhD

      Department of Laboratory Medicine, Division of Pathology-Lab Medicine Div

      Present Title & Affiliation

      Primary Appointment

      Professor, Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

      Medical Director, Laboratory Medicine, The University of Texas MD Anderson Cancer Center Regional Care Centers Laboratories, Houston

      Dual/Joint/Adjunct Appointment

      Professor, Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

      Professor, Pathology/Lab Medicine, School of Health Professions, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      1994Ohio State University, Columbus, Ohio, US, Microbiology, Ph.D
      1987Shanghai Medical University, Shanghai, CN, Epidemiology and Public Health, MPH
      1984Shanghai Medical University, Shanghai, CN, MD

      Postgraduate Training

      2008-2009Faculty Leadership Academy, The University of Texas MD Anderson Cancer Center, Houstion, Texas
      2007-2007Core Leadership Skills, The University of Texas MD Anderson Cancer Center, Houstion, Texas
      2005-2005Advance training program, Intermaintain Health Care, Salt Lake City, Utah
      1995-1999Resident, and Co-chief resident, Temple University Hospital, Philadelphia, Pennsylvania
      1995-1995Postdoctoral fellow, Ohio State University, Columbus, Ohio
      1984-1987Resident, Shanghai Medical University, Shanghai

      Licenses & Certifications

      2001Texas Medical Board
      1999Anatomical and Clinical Pathology
      1999Not specified

      Experience & Service

      Faculty Academic Appointments

      Assistant Professor (tenure track), Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 1999 - 2005

      Instructor, Department of Epidemiology, Shanghai Medical University, Shanghai, 1987 - 1989

      Administrative Appointments/Responsibilities

      Medical Director, Laboratory Medicine, The University of Texas MD Anderson Cancer Center Regional Care Centers Laboratories, Houston, 2007 - Present

      Deputy Department Chair, Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005 - 2009

      Assistant Director, General Services, The Universtiy of Texas M. D. Anderson Cancer Center, Houston, TX, 1999

      Other Professional Positions

      CAP inspector, Colleage of American Pathologists, Thomas Jefferson Medical Center, Philadelphia, 2009

      CAP inspector, College of American Pathologists, Nacogdoches Medical Center, Nacogdoches, TX, 2008

      CAP inspector, College of American Pathologists, West Houston Medical Center, Houston, 2006

      CAP inspector, Colleage of American Pathologists, Mills-Pennisula Medical Center, San Francisco, 2005

      CAP inspector, The University of California, San Diego, 2000

      CAP inspector, College of American Pathologists, UCSD Medical Center, 2000

      Extramural Institutional Committee Activities

      Member, Institutional Biosafety Committee, The University of Texas MD Anderson Cancer Center, 2003 - Present

      Member, Infection Control Subcommittee, The University of Texas MD Anderson Cancer Center, 2000 - Present

      Member, Clinical Research Symposium, The University of Texas MD Anderson Cancer Center, 1999

      Editorial Activities

      Member of editorial board, Journal of Clinical Microbiology, 2006

      Honors & Awards

      2004Educator of the month, The University of Texas MD Anderson Cancer Center
      2003Outstanding Educator Award, The University of Texas MD Anderson Cancer Center
      1993Sarber ASM award
      1992 - 1994Paul Hudson awards, Ohio Branch of ASM
      1984Academic Achievement award, Shanghai Medical University

      Selected Presentations & Talks

      Local Presentations

      1. 2008. Clinical Microbiology Update. Conference. Clinical Microbiology Update. Houston, TX, US.
      2. 2008. The Oldest Human Infection and New Insight. Conference. The Oldest Human Infection and New Insight. Houston, TX, US.
      3. 2004. Identification of bacteria through 16S rDNA sequencing. Conference. Identification of bacteria through 16S rDNA sequencing. Houston, TX, US.
      4. 2000. Lung nodules: diagnosis, management and etiology. Conference. Lung nodules: diagnosis, management and etiology. Houston, TX, US.
      5. 1999. Virus and cancer: some new insights into viral oncogenesis and diagnosis of viral infections. Conference. Virus and cancer: some new insights into viral oncogenesis and diagnosis of viral infections. Houston, TX, US.

      Regional Presentations

      1. 2003. Identification of bacteria through 16S rDNA sequencing. Conference. Identification of bacteria through 16S rDNA sequencing. San Antonio, US.

      National Presentations

      1. 2010. A gem from molecular microbiology: the discovery, phylogeny, and significance of the new leprosy-causing agent Mycobacterium lepromatosis. Conference. Trek Diagnostics, Inc. Houston, TX, US.
      2. 2006. Routine clinical microbiology practice and bacterial genetics. Conference. The annual Texas Genetics Symposium. Houston, TX, US.
      3. 2005. Diagnosis of infections in cancer patients. Conference. American Society of Clinical Pathology annual meeting. Seattle, WA, US.
      4. 2004. 16S rDNA sequencing to identify bacteria. Conference. Society of Clinical Laboratory Science annual meeting. Houston, US.
      5. 2003. Rapid and accurate identification of mycobacteria by 16S rDNA sequencing. Conference. American Society of Clinical Pathology Annual Meeting. New Orleans, US.

      International Presentations

      1. 2007. Infectious mass lesions in patients with cancer. Conference. Nanjing Medical University and Jiangsu Provincial Tumor Hospital. Nanjing, China, CN.
      2. 2007. Identification of bacteria through 16S rDNA sequencing. Conference. National University of Singapore. Singapore, SG.
      3. 2007. Diagnosis of infections in patients with cancer. Conference. Diagnosis of infections in patients with cancer. Singapore, SG.
      Read More
      Less

      Grant & Contract Support

      Date: 2003 - 2006
      Title:University Cancer Foundation
      Funding Source:UT M. D. Anderson Cancer Center
      Role:PI
      Date: 1999 - 2005
      Title:Research Start-up Fund
      Funding Source:UT M. D. Anderson Cancer Center
      Role:PI

      Selected Publications

      Peer-Reviewed Articles

      1. Romero-Navarrete M, Arenas R, Han XY, Vega-Memije ME, Castillo-Solana AD. Leprosy Caused by Mycobacterium lepromatosis. Am J Clin Pathol 158(6):678-686, 2022. e-Pub 2022. PMID: 36200553.
      2. Silva FJ, Santos-Garcia D, Zheng X, Zhang L, Han XY. Construction and Analysis of the Complete Genome Sequence of Leprosy Agent Mycobacterium lepromatosis. Microbiol Spectr 10(3):e0169221, 2022. e-Pub 2022. PMID: 35467405.
      3. Mehta H, Weng J, Prater A, Elworth RAL, Han X, Shamoo Y. Pathogenic Nocardia cyriacigeorgica and Nocardia nova Evolve To Resist Trimethoprim-Sulfamethoxazole by both Expected and Unexpected Pathways. Antimicrob Agents Chemother 62(7), 2018. e-Pub 2018. PMID: 29686152.
      4. Han XY. Detection of the Leprosy Agent Mycobacterium lepromatosis in South America and Europe. Am J Trop Med Hyg 96(1):260, 2017. e-Pub 2017. PMID: 27879462.
      5. Zou LJ, Deng XG, Han XY, Tan WR, Zhu LJ, Xi DH, Zhang DW, Lin HH. Role of Transcription Factor HAT1 in Modulating Arabidopsis thaliana Response to Cucumber mosaic virus. Plant Cell Physiol 57(9):1879-89, 2016. e-Pub 2016. PMID: 27328697.
      6. Shroff GS, Marom EM, Wu CC, Godoy MC, Wei W, Ihegword A, Han XY, Truong MT. Pulmonary Legionellosis in Oncologic Patients: Findings on Chest CT. e-Pub 2016. PMID: 27454787.
      7. Han XY, Quintanilla M. A case of diffuse lepromatous leprosy due to Mycobacterium lepromatosis in Quintana Roo, Mexico. J Clin Microbiol. e-Pub 2015. PMID: 26311856.
      8. Han XY, Zhang J, Li L. The Leprosy Agents Mycobacterium lepromatosis and Mycobacterium leprae in Mexico: A Clarification. J Clin Microbiol. e-Pub 2015. PMID: 26224842.
      9. Han XY, Ihegword A, Evans SE, Zhang J, Li L, H' C, Tarrand JJ, El-Kweifi O. Microbiological and Clinical Studies of Legionellosis in 33 Patients with Cancer. J Clin Microbiol. e-Pub 2015. PMID: 25926494.
      10. Li L, Tarrand JJ, Han XY. Four Cases of Catheter-related Infection by Methylobacterium radiotolerans: Microbiologic and Clinical Features. J Clin Microbiol. e-Pub 2015. PMID: 25631797.
      11. Han XY, Mistry NA, Thompson EJ, Tang HL, Khanna K, Zhang L. Draft Genome Sequence of New Leprosy Agent Mycobacterium lepromatosis. Genome Announc 3(3), 2015. e-Pub 2015. PMID: 25999555.
      12. Han XY, Aung FM, Choon SE, Werner B. Analysis of the Leprosy Agents Mycobacterium leprae and Mycobacterium lepromatosis in Four Countries. Am J Clin Pathol 142(4):524-32, 2014. e-Pub 2014. PMID: 25239420.
      13. Wang HL, Seo YH, LaSala PR, Tarrand JJ, Han XY. Nocardiosis in 132 patients with cancer: microbiological and clinical analyses. Am J Clin Pathol 142(4):513-23, 2014. e-Pub 2014. PMID: 25239419.
      14. Galloway-Peña J, Sahasrabhojane P, Tarrand J, Han XY, Shelburne SA. GyrB Polymorphisms Accurately Assign Invasive Viridans Group Streptococcal Species. J Clin Microbiol. e-Pub 2014. PMID: 24899021.
      15. Ricci KS, Martinez F, Lichtiger B, Han XY. Septic transfusion reactions during blood transfusion via indwelling central venous catheters. Transfusion. e-Pub 2014. PMID: 24725023.
      16. Tran QT, Han XY. Subspecies Identification and Significance of 257 Clinical Strains of Mycobacterium avium. J Clin Microbiol. e-Pub 2014. PMID: 24501026.
      17. Han XY, Silva FJ. On the age of leprosy. PLoS Negl Trop Dis 8(2):e2544, 2014. e-Pub 2014. PMID: 24551248.
      18. Yilmaz M, Chemaly RF, Han XY, Thall PF, Fox PS, Tarrand JJ, De Lima MJ, Hosing CM, Popat UR, Shpall E, Champlin RE, Qazilbash MH. Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience. Bone Marrow Transplant. e-Pub 2013. PMID: 23503529.
      19. El Helou G, Viola GM, Hachem R, Han XY, Raad II. Rapidly growing mycobacterial bloodstream infections. Lancet Infect Dis 13(2):166-74, 2013. e-Pub 2013. PMID: 23347634.
      20. Han XY, Jessurun J. Severe Leprosy Reactions Due to Mycobacterium lepromatosis. Am J Med Sci 345(1):65-9, 2013. e-Pub 2013. PMID: 23111393.
      21. Cano P, Han FS, Wang HL, Fernandez-Vina M, Han XY. Cytokine gene polymorphisms affect reactivation of cytomegalovirus in patients with cancer. Cytokine. e-Pub 2012. PMID: 22898395.
      22. Han XY, Sizer KC, Velarde-Félix JS, Frias-Castro LO, Vargas-Ocampo F. The leprosy agents Mycobacterium lepromatosis and Mycobacterium leprae in Mexico. Int J Dermatol 51(8):952-9, 2012. e-Pub 2012. PMID: 22788812.
      23. Tarrand JJ, LaSala PR, Han XY, Rolston KV, Kontoyiannis DP. Dimethyl sulfoxide enhances the effectiveness of skin antiseptics and reduces the contamination rates of blood cultures. J Clin Microbiol 50(5):1552-7, 2012. e-Pub 2012. PMID: 22378911.
      24. Bal TA, Armstrong G, Han XY. Evaluation of the IMMULITE® 2000 CMV IgM assay. Herpesviridae 3(1):2, 2012. e-Pub 2012. PMID: 22377002.
      25. Simmon KE, Fang DC, Tesic V, Khot PD, Giangeruso E, Bolesta ES, Wagner-Reiss KM, Fisher MA, Petti CA, Han XY, She RC. Isolation and characterization of ”Pseudomonas andersonii” from four cases of pulmonary granulomas and emended species description. J Clin Microbiolo 49, 2011. e-Pub 2011.
      26. Han XY, Tarrrand JJ, Dickey BF, Esteva FJ. Helicobacter pylori bacteremia with sepsis syndrome. J Clin Microbiol 48(12):4661-4663, 2010. e-Pub 2010.
      27. Tarrand JJ, Keating MJ, Tsimberidou AM, O'Brien S, LaSala RP, Han XY, Bueso-Ramos CE. Epstein-Barr virus latent membrane protein 1 mRNA is expressed in a significant proportion of patients with chronic lymphocytic leukemia. Cancer 116(4):880-7, 2010. e-Pub 2010. PMID: 20052729.
      28. Tarrrand JJ, Keating MJ, Tsimberido AM, O'braien S, LaSala PR, Han XY, Bueso-Ramos. Epstein Barr Virus latent membrane protein 1 mRNA is expressed in a significant portion of patients with chronix lymphocytic Leukemia. Cancer 116(4):880-887, 2010. e-Pub 2010.
      29. Buscher A, Li L, Han XY, Trautner BW. Aortic valve endocarditis possibly caused by a Haematobacter-like species. J Clin Microbiol 48(10):3791-93, 2010. e-Pub 2010.
      30. De Padua Silva L, Patah PA, Saliba RM, Szewczyk NA, Gilman L, Neumann J, Han XY, Tarrand J, Ribeiro R, Gulbis A, Shpall EJ, Jones R, Popat U, Walker JA, Petropoulos D, El-Zimaity M, Chiattone A, Stewart J, Anderlini P, Giralt S, Champlin RE, De Lima M. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type. Haematologica 95(7):1183-90, 2010. e-Pub 2010.
      31. Han XY, Sizer KC, Thompson EJ, Kabanja J, Li J, Hu P, Gómez-Valero L, Silva FJ. Comparative sequence analysis of Mycobacterium leprae and the new leprosy-causing Mycobacterium lepromatosis. J Bacteriol 191(19):6067-74, 2009. e-Pub 2009. PMID: 19633074.
      32. LaSala PR, Yarsa J, Nguyen DV, Han XY, Tarrand J. Evaluation of an abbreviated protocol for cytomegalovirus pp65 antigenemia testing. Am J Clin Pathol 131(4):526-31, 2009. e-Pub 2009. PMID: 19289588.
      33. Han XY, Seo YH, Sizer KC, Schoberle T, May GS, Spencer JS, Li W, Nair RG. A new Mycobacterium species causing diffuse lepromatous leprosy. Am J Clin Pathol 130(6):856-64, 2008. e-Pub 2008. PMID: 19019760.
      34. Han XY. Seasonality of clinical isolation of rapidly growing mycobacteria. Epidemiol Infect 136(9):1188-91, 2008. e-Pub 2008. PMID: 18005476.
      35. Han XY, Han FS, Segal J. Chromobacterium haemolyticum sp. nov., a strongly haemolytic species. Int J Syst Evol Microbiol 58(Pt 6):1398-403, 2008. e-Pub 2008. PMID: 18523185.
      36. Han XY, Dé I, Jacobson KL. Rapidly growing mycobacteria: clinical and microbiologic studies of 115 cases. Am J Clin Pathol 128(4):612-21, 2007. e-Pub 2007. PMID: 17875513.
      37. Ghanem G, Adachi J, Han XY, Raad I. Central venous catheter-related Streptomyces septic thrombosis. Infect Control Hosp Epidemiol 28(5):599-601, 2007. e-Pub 2007. PMID: 17464923.
      38. Kapadia M, Rolston KV, Han XY. Invasive Streptomyces infections: six cases and literature review. Am J Clin Pathol 127(4):619-24, 2007. e-Pub 2007. PMID: 17369139.
      39. Carlier JP, K'ouas G, Han XY. Moryella indoligenes gen. nov., sp. nov., an anaerobic bacterium isolated from clinical specimens. Int J Syst Evol Microbiol 57(Pt 4):725-9, 2007. e-Pub 2007. PMID: 17392195.
      40. Oh Y, Varmanen P, Han XY, Bennett G, Xu Z, Lu T, Palva A. Lactobacillus plantarum for oral peptide delivery. Oral Microbiol Immunol 22(2):140-4, 2007. e-Pub 2007. PMID: 17311639.
      41. Han XY. Epidemiologic analysis of reactivated cytomegalovirus antigenemia in patients with cancer. J Clin Microbiol 45(4):1126-32, 2007. e-Pub 2007. PMID: 17287334.
      42. LaSala PR, Segal J, Han FS, Tarrand JJ, Han XY. First reported infections caused by three newly described genera in the family xanthomonadaceae. J Clin Microbiol 45(2):641-4, 2007. e-Pub 2007. PMID: 17122001.
      43. Ansari SR, Safdar A, Han XY, O'Brien S. Nocardia veterana bloodstream infection in a patient with cancer and a summary of reported cases. Int J Infect Dis 10(6):483-6, 2006. e-Pub 2006. PMID: 16876454.
      44. Han XY, Hong T, Falsen E. Neisseria bacilliformis sp. nov. isolated from human infections. J Clin Microbiol 44(2):474-9, 2006. e-Pub 2006. PMID: 16455901.
      45. Taj-Aldeen SJ, Doiphode SH, Han XY. Kodamaea (Pichia) ohmeri fungaemia in a premature neonate. J Med Microbiol 55(Pt 2):237-9, 2006. e-Pub 2006. PMID: 16434718.
      46. Han XY, Kamana M, Rolston KV. Viridans streptococci isolated by culture from blood of cancer patients: clinical and microbiologic analysis of 50 cases. J Clin Microbiol 44(1):160-5, 2006. e-Pub 2006. PMID: 16390964.
      47. Han XY. Cardiobacterium valvarum endocarditis. Ann Intern Med 143(8):614, 2005. e-Pub 2005. PMID: 16230732.
      48. Han XY, Tarrand JJ, Infante R, Jacobson KL, Truong M. Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare among patients without AIDS. J Clin Microbiol 43(9):4407-12, 2005. e-Pub 2005. PMID: 16145084.
      49. Han XY, Andrade RA. Brevundimonas diminuta infections and its resistance to fluoroquinolones. J Antimicrob Chemother 55(6):853-9, 2005. e-Pub 2005. PMID: 15883180.
      50. Han XY, Tarrand JJ, Rice DC. Oral Campylobacter species involved in extraoral abscess: a report of three cases. J Clin Microbiol 43(5):2513-5, 2005. e-Pub 2005. PMID: 15872299.
      51. Han XY, Falsen E. Characterization of oral strains of Cardiobacterium valvarum and emended description of the organism. J Clin Microbiol 43(5):2370-4, 2005. e-Pub 2005. PMID: 15872268.
      52. Han XY, Lin P, Amin HM, Ferrajoli A. Postsplenectomy cytomegaloviral mononucleosis: marked lymphocytosis, TCRgamma gene rearrangements, and impaired IgM response. Am J Clin Pathol 123(4):612-7, 2005. e-Pub 2005. PMID: 15743745.
      53. Xiong Q, Hassan SA, Wilson WK, Han XY, May GS, Tarrand JJ, Matsuda SP. Cholesterol import by Aspergillus fumigatus and its influence on antifungal potency of sterol biosynthesis inhibitors. Antimicrob Agents Chemother 49(2):518-24, 2005. e-Pub 2005. PMID: 15673727.
      54. Tarrand JJ, Han XY, Kontoyiannis DP, May GS. Aspergillus hyphae in infected tissue: evidence of physiologic adaptation and effect on culture recovery. J Clin Microbiol 43(1):382-6, 2005. e-Pub 2005. PMID: 15634998.
      55. Lewis RE, Wiederhold NP, Chi J, Han XY, Komanduri KV, Kontoyiannis DP, Prince RA. Detection of gliotoxin in experimental and human aspergillosis. Infect Immun 73(1):635-7, 2005. e-Pub 2005. PMID: 15618207.
      56. Han XY, Ho LX, Safdar A. Francisella tularensis peritonitis in stomach cancer patient. Emerg Infect Dis 10(12):2238-40, 2004. e-Pub 2004. PMID: 15663872.
      57. Lee SA, Raad II, Adachi JA, Han XY. Catheter-related bloodstream infection caused by Mycobacterium brumae. J Clin Microbiol 42(11):5429-31, 2004. e-Pub 2004. PMID: 15528764.
      58. Dé I, Rolston KV, Han XY. Clinical significance of Roseomonas species isolated from catheter and blood samples: analysis of 36 cases in patients with cancer. Clin Infect Dis 38(11):1579-84, 2004. e-Pub 2004. PMID: 15156446.
      59. Han XY, Meltzer MC, Woods JT, Fainstein V. Endocarditis with ruptured cerebral aneurysm caused by Cardiobacterium valvarum sp. nov. J Clin Microbiol 42(4):1590-5, 2004. e-Pub 2004. PMID: 15071009.
      60. Han XY, Tarrand JJ. Moraxella osloensis blood and catheter infections during anticancer chemotherapy: clinical and microbiologic studies of 10 cases. Am J Clin Pathol 121(4):581-7, 2004. e-Pub 2004. PMID: 15080311.
      61. Cohen MF, Han XY, Mazzola M. Molecular and physiological comparison of Azospirillum spp. isolated from Rhizoctonia solani mycelia, wheat rhizosphere, and human skin wounds. Can J Microbiol 50(4):291-7, 2004. e-Pub 2004. PMID: 15213753.
      62. Han XY, Weinberg JS, Prabhu SS, Hassenbusch SJ, Fuller GN, Tarrand JJ, Kontoyiannis DP. Fusobacterial brain abscess: a review of five cases and an analysis of possible pathogenesis. J Neurosurg 99(4):693-700, 2003. e-Pub 2003. PMID: 14567605.
      63. Antoniadou A, Torres HA, Lewis RE, Thornby J, Bodey GP, Tarrand JP, Han XY, Rolston KV, Safdar A, Raad, II, Kontoyiannis DP. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Medicine (Baltimore) 82(5):309-21, 2003. e-Pub 2003. PMID: 14530780.
      64. Han XY, Pham AS, Tarrand JJ, Rolston KV, Helsel LO, Levett PN. Bacteriologic characterization of 36 strains of Roseomonas species and proposal of Roseomonas mucosa sp nov and Roseomonas gilardii subsp rosea subsp nov. Am J Clin Pathol 120(2):256-64, 2003. e-Pub 2003. PMID: 12931556.
      65. Tarrand JJ, Lichterfeld M, Warraich I, Luna M, Han XY, May GS, Kontoyiannis DP. Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol 119(6):854-8, 2003. e-Pub 2003. PMID: 12817433.
      66. Pham AS, Dé I, Rolston KV, Tarrand JJ, Han XY. Catheter-related bacteremia caused by the nocardioform actinomycete Gordonia terrae. Clin Infect Dis 36(4):524-7, 2003. e-Pub 2003. PMID: 12567313.
      67. Pham AS, Tarrand JJ, May GS, Lee MS, Kontoyiannis DP, Han XY. Diagnosis of invasive mold infection by real-time quantitative PCR. Am J Clin Pathol 119(1):38-44, 2003. e-Pub 2003. PMID: 12520695.
      68. Han XY, Pham AS, Tarrand JJ, Sood PK, Luthra R. Rapid and accurate identification of mycobacteria by sequencing hypervariable regions of the 16S ribosomal RNA gene. Am J Clin Pathol 118(5):796-801, 2002. e-Pub 2002. PMID: 12428802.
      69. Han XY, Anderlini P, Tarrand J. Diagnosis and monitoring of primary cytomegalovirus infection by antigenemia test. Bone Marrow Transplant 30(6):411, 2002. e-Pub 2002. PMID: 12235529.
      70. Narvios A, Pena E, Han XY, Lichtiger B. Cytomegalovirus infection in cancer patients receiving granulocyte transfusions. Blood 99(9):3483-4, 2002. e-Pub 2002.
      71. Oh Y, Osato MS, Han X, Bennett G, Hong WK. Folk yoghurt kills Helicobacter pylori. J Appl Microbiol 93(6):1083-8, 2002. e-Pub 2002. PMID: 12452966.
      72. Han XY, Pham AS, Nguyen KU, Smythe WR, Ordonez NG, Jacobson KL, Tarrand JJ. Pulmonary granuloma caused by Pseudomonas andersonii sp nov. Am J Clin Pathol 116(3):347-53, 2001. e-Pub 2001. PMID: 11554162.
      73. Kontoyiannis DP, Peitsch WK, Reddy BT, Whimbey EE, Han XY, Bodey GP, Rolston KV. Cryptococcosis in patients with cancer. Clin Infect Dis 32(11):E145-50, 2001. e-Pub 2001. PMID: 11340547.
      74. Han XY, Wu SS, Conway DH, Pawel BR, Punnett HH, Martin RA, de Chadarevian JP. Truncus arteriosus and other lethal internal anomalies in Goltz syndrome. Am J Med Genet 90(1):45-8, 2000. e-Pub 2000. PMID: 10602117.
      75. Han XY, Truant AL. The detection of positive blood cultures by the AccuMed ESP-384 system: the clinical significance of three-day testing. Diagn Microbiol Infect Dis 33(1):1-6, 1999. e-Pub 1999. PMID: 9990468.
      76. Wozniak DJ, Han XY, Galloway DR. Construction and use of a nontoxigenic strain of Pseudomonas aeruginosa for the production of recombinant exotoxin A. Appl Environ Microbiol 61(5):1739-44, 1995. e-Pub 1995. PMID: 7646011.
      77. Han XY, Galloway DR. Active site mutations of Pseudomonas aeruginosa exotoxin A. Analysis of the His440 residue. J Biol Chem 270(2):679-84, 1995. e-Pub 1995. PMID: 7822295.
      78. Ye, Tsai TF, Han XY, Min JG, Xu ZY. Isolation of arboviruses by plaque assays. . Acta Academiae Medicinae Shanghai 17:35-8, 1990. e-Pub 1990.
      79. Ye, Han XY, Xu SS, Chang HX, Tian MY. Serosurvey of maternally derived antibodies against Japanese encephalitis and measles. . Acta Academiae Medicinae Shanghai 17:27-30, 1990. e-Pub 1990.
      80. Hanau D, Fabre M, Schmitt DA, Lepoittevin JP, Stampf JL, Grosshans E, Benezra C, Cazenave JP. ATPase and morphologic changes in Langerhans cells induced by epicutaneous application of a sensitizing dose of DNFB. J Invest Dermatol 92(5):689-94, 1989. e-Pub 1989. PMID: 2523942.
      81. Han XY, Tsai TF, Ren QW, Xu ZY. Infection of alpha-togaviruses: a case report from Anhui, China. . Shanghai Medical Journal 12:186, 1989. e-Pub 1989.
      82. Han XY, Xu ZY, Wang JX. Serosurvey of antibodies against Japanese encephalitis by ELISA in Shanghai. . Shanghai Medical Journal 12:35-7, 1989. e-Pub 1989.
      83. Han XY, Ren QW, Xu ZY, Tsai TF. Serum and cerebrospinal fluid immunoglobulins M, A, and G in Japanese encephalitis. J Clin Microbiol 26(5):976-8, 1988. e-Pub 1988. PMID: 2838511.
      84. Han XY, Xu ZY. Evaluation of enzyme-linked immunosorbent assays in the detection of antibodies against Japanese encephalitis in swine sera. . Chinese Journal of Zoonoses 4:30-2, 1988. e-Pub 1988.
      85. Han XY, Pan ZF, Liu XM, Tan CY, Xiao ZP, Xu ZY. Investigation of the prevalence of hepatitis A outbreak in Minhang District, Shanghai. . Acta Academiae Medicinae Shanghai 15:360-5, 1988. e-Pub 1988.
      86. Han XY, Wu ZM, Yuan GJ, Xu ZY. Vaccination against Japanese encephalitis and long-term change of the disease prevalence in Shanghai. . Acta Academiae Medicinae Shanghai 15:280-4, 1988. e-Pub 1988.

      Review Articles

      1. Han XY, Sizer KC, Tan HH. Identification of the leprosy agent Mycobacterium lepromatosis in Singapore. J Drugs Dermatol 11(2):168-72, 2012. e-Pub 2012. PMID: 22270197.
      2. Han XY, Hellerstedt BA, Koller CA. Postsplenectomy cytomegalovirus mononucleosis is a distinct clinicopathologic syndrome. Am J Med Sci 339(4):395-9, 2010. e-Pub 2010. PMID: 20195147.
      3. Safdar A, Han XY. Mycobacterium lentiflavum, a recently identified slow-growing mycobacterial species: clinical significance in immunosuppressed cancer patients and summary of reported cases of infection. Eur J Clin Microbiol Infect Dis 24(8):554-8, 2005. e-Pub 2005. PMID: 16133412.
      4. Han XY, Tarrand JJ, Escudero E. Infections by the yeast Kodomaea (Pichia) ohmeri: two cases and literature review. Eur J Clin Microbiol Infect Dis 23(2):127-30, 2004. e-Pub 2004. PMID: 14722784.
      5. Hong DS, Jacobson KL, Raad II, de Lima M, Anderlini P, Fuller GN, Ippoliti C, Cool RM, Leeds NE, Narvios A, Han XY, Padula A, Champlin RE, Hosing C. West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review. Clin Infect Dis 37(8):1044-9, 2003. e-Pub 2003. PMID: 14523768.

      Professional Educational Materials

      1. Han XY. Standard of operation protocol for the identification of mycobacteria by PCR and nucleotide sequencing analysis. MDACC, 2002.

      Other Articles

      1. Cano P, Han FS, Fernandez-Vino M, Han XY Cytokine gene polymorphisms and reactivation of cytomegalovirus. Journal of Virology.
      2. Han XY, Sizer KC, Velarde-Felix JS, Frias-Castro LO Leprosy in Mexico: etiologic agents, diagnoses, and geographic distribution. Emerging Infect Dis.
      3. Seo YH, Han XY, Chen SS, Tarrand JJ, LaSala PR Nocardiosis in patients with cancer. Journal of Clinical Microbiology.

      Abstracts

      1. Cano P, Han FS, Fernandez-Vino M, Han XY. Cytokine gene polymorphisms and reactivation of cytomegalovirus: a case control study. Am Soc of Histocomp and Immunogen annual meeting, 2009. e-Pub 2009.
      2. Seo YH, Han XY. Nocardiosis in patients with cancer: clinical and microbiologic analysis of 45 cases. Am Soc Microbiol annual meeting, 2007. e-Pub 2007.
      3. Drury S, Alpaugh W, Han XY, Y Kang Y. Rapid Identification of Mycobacteria species in Difficult and Contaminated Clinical Specimen by DNA Sequencing Method. Am Soc Clin Pathol annual meeting, 2006. e-Pub 2006.

      Book Chapters

      1. Han XY. Infections of soft tissue and prosthetic devices. In: Diagnostic Microbiology of the Immunocompromised Host. ASM press, 2008.
      2. Han XY. Automated blood culture system. In: Advanced Techniques in Diagnostic Microbiology. Springer-Verlag, 2006.
      3. Han XY. Bacterial identification based on 16S rRNA gene sequence analysis. In: Advanced Techniques in Diagnostic Microbiology. Springer-Verlag, 2006.

      Books (edited and written)

      1. Han XY. Structure-function studies of Pseudomonas aeruginosa exotoxin A. The Ohio St Univ, 1994.

      Letters to the Editor

      1. Han XY. Misdiagnosis of Mycobacterium brumae infection. J Clin Microbiol 49: 1190-92, 2011.
      2. Han XY. Mycobacterium neoaurum contamination. Emerg Infect Dis 11: 1316-7; author reply 1317, 2005.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top